Skip to main content
. Author manuscript; available in PMC: 2021 Apr 11.
Published in final edited form as: Gynecol Oncol. 2020 Aug 23;159(2):509–514. doi: 10.1016/j.ygyno.2020.08.015

Fig. 1.

Fig. 1.

Aromatase Inhibitor Side Effects and Reasons for Discontinuation. (A) Side effect rates. Medical record chart review revealed that over half of patients (54.1%, 79 patients) reported at least one AI-associated side effect within the first three visits of starting an aromatase inhibitor. (B) Reasons for AI discontinuation. A total of 99 patients discontinued aromatase inhibitor therapy during the reviewed treatment period. Rates and reasons for discontinuation are shown.